Loading...
Docoh

Darling Ingredients (DAR)

Darling Ingredients Inc. is one of the world's leading producers of organic ingredients, producing a wide array of sustainable protein and fat products while being one of the largest producers of renewable clean energy. With operations on five continents, Darling collects waste streams from the agri-food industry, repurposing into specialty ingredients, such as hydrolyzed collagen, edible and feed-grade fats, animal proteins and meals, plasma, pet food ingredients, fuel feedstocks, and green bioenergy. The Company sells its products around the globe and works to strengthen its promise for a better tomorrow, creating product applications for health, nutrients and bioenergy while optimizing its services to the food chain. Darling is a 50% joint partner in Diamond Green Diesel (DGD), North America's largest renewable diesel manufacturer, currently producing approximately 290 million gallons of renewable diesel annually which products reduce Green House Gas (GHG) emissions by up to 85% compared to fossil fuels.

Company profile

Ticker
DAR
Exchange
CEO
Randall Stuewe
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DARLING INTERNATIONAL INC
SEC CIK
Subsidiaries
Griffin Industries LLC • Craig Protein Division, Inc. • Darling National LLC • Darling Green Energy LLC • EV Acquisition LLC • Darling Global Holdings Inc. • Darling International Netherlands B.V. • Darling International Canada Inc. • Darling International NL Holdings B.V. • Darling Global Finance B.V. ...
IRS number
362495346

DAR stock data

Analyst ratings and price targets

Last 3 months

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

10 May 22
2 Jul 22
31 Dec 22
Quarter (USD) Apr 22 Jan 22 Oct 21 Jul 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Jan 22 Jan 21 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
2 Jun 22 John Bullock Common Stock Sell Dispose S No No 82.7 12,374 1.02M 109,496
2 Jun 22 John Bullock Common Stock Payment of exercise Dispose F No No 82.7 11,589 958.41K 121,870
2 Jun 22 John Bullock Common Stock Option exercise Acquire M No No 12.29 23,963 294.51K 133,459
2 Jun 22 John Bullock Options Common Stock Option exercise Dispose M No No 12.29 23,963 294.51K 0
1 Jun 22 Jim Long Common Stock Sell Dispose S No No 80.82 25,000 2.02M 48,489
27 May 22 John Bullock Common Stock Sell Dispose S No No 81.34 12,872 1.05M 109,496
27 May 22 John Bullock Common Stock Payment of exercise Dispose F No No 81.34 12,128 986.49K 122,368
27 May 22 John Bullock Common Stock Option exercise Acquire M No No 12.29 25,000 307.25K 134,496
27 May 22 John Bullock Options Common Stock Option exercise Dispose M No No 12.29 25,000 307.25K 23,963
26 May 22 John Bullock Common Stock Sell Dispose S No No 80 21,790 1.74M 109,496
91.5% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 500 458 +9.2%
Opened positions 91 74 +23.0%
Closed positions 49 66 -25.8%
Increased positions 182 166 +9.6%
Reduced positions 162 168 -3.6%
13F shares Current Prev Q Change
Total value 27.98B 10.9B +156.8%
Total shares 147.71M 149.23M -1.0%
Total puts 1.02M 703.8K +44.4%
Total calls 845.3K 631.6K +33.8%
Total put/call ratio 1.2 1.1 +7.9%
Largest owners Shares Value Change
BLK Blackrock 16.99M $1.37B -6.3%
Vanguard 16.31M $1.31B -1.1%
TROW T. Rowe Price 9.24M $743.03M +167.3%
FMR 7.07M $568.42M -13.5%
FIL 4.59M $368.84M +0.1%
STT State Street 4.56M $366.17M +4.8%
Handelsbanken Fonder AB 4.52M $363.27M -12.9%
Earnest Partners 3.95M $317.38M -2.7%
Dimensional Fund Advisors 3.73M $299.73M -26.6%
IPXAF Impax Asset Management 3.7M $296.3M -8.5%
Largest transactions Shares Bought/sold Change
TROW T. Rowe Price 9.24M +5.79M +167.3%
Marshall Wace 2.3M -1.83M -44.3%
Norges Bank 0 -1.42M EXIT
Dimensional Fund Advisors 3.73M -1.35M -26.6%
AMP Ameriprise Financial 1.56M +1.27M +429.3%
Parsifal Capital Management 0 -1.26M EXIT
BLK Blackrock 16.99M -1.14M -6.3%
FMR 7.07M -1.1M -13.5%
Handelsbanken Fonder AB 4.52M -669.49K -12.9%
Korea Investment 557.07K +557.07K NEW

Financial report summary

?
Competition
Tyson FoodsRenewable Energy
Management Discussion
  • •Non-U.S. GAAP measures
  • These indicators and their importance are discussed below.
  • Prices for finished product commodities that the Company produces in the Feed Ingredients segment are reported each business day on the Jacobsen Index (the “Jacobsen”), an established North American trading exchange price publisher. The Jacobsen reports industry sales from the prior day's activity by product. Included on the Jacobsen are reported prices for finished products such as protein (primarily meat and bone meal (“MBM”), poultry meal (“PM”) and feather meal (“FM”)), hides, fats (primarily bleachable fancy tallow (“BFT”) and yellow grease (“YG”)) and corn, which is a substitute commodity for the Company's bakery by-product (“BBP”) as well as a range of other branded and value-added products, which are products of the Company's Feed Ingredients segment. In the United States, the Company regularly monitors the Jacobsen for MBM, PM, FM, BFT, YG and corn because it provides a daily indication of the Company's U.S. revenue performance against business plan benchmarks. In Europe, the Company regularly monitors Thomson Reuters (“Reuters”) to track the competing commodities palm oil and soy meal.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. senior Bad
New words: anniversary, atmosphere, Beeck, California, catalyst, CDOR, closure, customary, de, deflationary, delayed, delta, digester, dioxide, efficacy, enforce, ESG, ESTR, EURIBOR, evolve, evolving, extreme, FASA, frequency, GmbH, growth, increasingly, independent, inflationary, life, macroeconomic, magnify, mandated, monitor, necessitate, omicron, Op, overnight, post, preliminary, principle, priority, rapidly, recessionary, regional, RFS, simple, SOFR, SONIA, stakeholder, Sterling, stringent, supplemental, suspension, technology, transitional, turnaround, unable, USD, Valley, war, weakened
Removed: amortized, arrive, ASU, authorized, back, beginning, begun, caption, case, casualty, characterized, collateral, condensed, consent, consistency, consolidating, constitute, Craig, DarPro, declared, disrupt, distancing, Division, Dubuque, dynamic, Emergency, essential, experienced, fully, Griffin, half, high, incurrence, indirectly, issuer, issuing, license, lowest, mechanism, notified, Notwithstanding, organized, Peabody, permitted, prolonged, promotion, reinstated, relaxed, remained, retroactively, RIN, Rothsay, security, separate, Simplifying, slightly, Storage, supporting, taxable, threat, Topic, ultimately, unconditional, unconditionally, USA, weaker, workplace

Patents

Utility
Protein Based Excipient for Active Pharmaceutical Ingredients
10 Mar 22
Provided herein is a pharmaceutical formulation comprising a protein based excipient in combination with an active pharmaceutical ingredient (API) wherein said formulation is substantially amorphous and form a substantially homogenous mixture; and further a method for producing said pharmaceutical formulation; and said pharmaceutical formulation for use as a medicament.
Utility
Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis
7 Sep 21
The invention generally relates to pharmaceuticals and/or nutraceuticals.
Utility
Low Cross-linking Gelatine
2 Dec 20
The present invention relates to a process for the preparation of a gelatine blend comprising the steps of a) providing a gelatine extract or a series of gelatine extracts, differing in bloom and viscosity; b) subjecting a portion of one or more of the gelatine extracts of a) to an enzymatic treatment to obtain one or more enzymatically treated extracts having a viscosity that is lower than that of the respective extract before said enzymatic treatment, while maintaining the bloom substantially unaffected, the enzymatically treated extracts comprising less than 1.5 w/w % of gelatine-derived peptides having a molecular weight of less than 2000 Da; c) selecting one or more gelatine extracts of step a); d) combine the selected one or more gelatine extracts of step c) and blend with one or more enzymatically treated extracts of step b) to provide a gelatine composition having a lower viscosity as compared to that of the said combined selected extracts of step c) without being blended with said selected one or more enzymatically treated gelatine extracts of step b), while maintaining the bloom substantially unaffected.
Utility
Compositions of Hydrolyzed Collagen Peptides and Commensal Microorganisms and Methods Thereof
4 Mar 20
The invention generally relates to pharmaceuticals and/or nutraceuticals.